TCM Clinical Trials Adopt CONSORT Standards

How TCM clinical trials are embracing CONSORT to meet global scientific rigor—impacting regulatory acceptance, international中医药临床试验, and WHO integration (Updated: June 2026).

2026-06-02

Digital Health Platforms Enable Remote TCM Consultations ...

How digital health platforms are scaling remote TCM consultations globally — from AI-assisted diagnosis to WHO-aligned standards and cross-border clinical integration.

2026-06-02

Herbal Drug RCTs Align With ICH Guidelines for Global App...

How rigorously designed herbal drug RCTs—fully compliant with ICH E6(R3), E8(R2), and E17—are unlocking FDA, EMA, and PMDA approvals. Real-world case studies, regulatory pathways, and pitfalls avoi...

2026-06-02

Acupuncture Globalization Meets Evidence Based Clinical V...

How acupuncture globalization is converging with rigorous clinical validation—AI diagnostics, WHO strategy alignment, EU/FDA regulatory pathways, and real-world trials (Updated: June 2026).

2026-06-02

International TCM Education Programs Foster Cross Cultura...

How global TCM education programs build cross-cultural clinical fluency—bridging循证中医, AI-assisted diagnosis, and WHO-aligned standards across US, EU, and Belt & Road markets (Updated: June 2026)....

2026-06-01

Global Medical Tourism Boosts Demand for Authentic TCM Care

How medical tourism is accelerating demand for evidence-based, standardized TCM care — from AI-assisted diagnostics to WHO-aligned clinical trials and cross-border practice in the US and EU.

2026-06-01

Big Data Decodes Classical Formulas for Evidence Based TCM

How big data analytics, AI-assisted diagnostics, and rigorous clinical trials are transforming Traditional Chinese Medicine into a globally trusted, evidence-based system — with real-world adoption...

2026-06-01

EU Herbal Regulations Impact TCM International Registration

How EU herbal regulations reshape TCM international registration—practical insights on compliance, clinical trial design, and market access for herbal products in Europe (Updated: June 2026).

2026-06-01

Chinese Medicine in the US: FDA Regulatory Pathways

Practical guide to navigating FDA requirements for TCM products and practices in the US — from herbal supplements to AI-assisted diagnostics and clinical trial design.

2026-06-01

Standardization Challenges in Global TCM Implementation

Examining real-world barriers to scaling Traditional Chinese Medicine globally — from FDA-equivalent herb registration hurdles to WHO-aligned clinical trial design and AI-assisted diagnostics.

2026-06-01